Transoral robotic surgery using CO(2) laser in oropharyngeal squamous cell carcinoma: a clinical case series

经口机器人手术联合二氧化碳激光治疗口咽鳞状细胞癌:临床病例系列研究

阅读:1

Abstract

PURPOSE: Transoral robotic surgery (TORS) is an established surgical approach for oropharyngeal squamous cell carcinoma (OPSCC). Carbon dioxide (CO₂) laser offers high cutting precision and minimal collateral thermal injury, yet its use in TORS remains underreported. The purpose of this study is therefore to describe the first UK case series detailing the use of CO₂ laser via hollow waveguide in TORS. METHODS: Eight patients (six male, two female; mean age 60 years) presenting with either left tonsillar (seven cases) or right tongue base (one case) OPSCC underwent primary TORS resection with CO₂ laser at a tertiary UK head and neck centre between October 2020 and May 2024. Cases were selected based on tumour stage, anatomical suitability and patient preference. The CO₂ laser (SmartXide Trio, 3-10 W, ultra-pulse mode) was delivered via hollow waveguide mounted on one of the arms of the Da Vinci robotic system. Outcome measures included histological margin status, peri- and postoperative complications, swallowing function, and hospital length of stay. RESULTS: All tumours were completely excised; two of the eight had close margins on the primary specimen but were clear on additional sampling. No intraoperative complications occurred, and all procedures were completed without conversion. All patients resumed oral intake without nasogastric feeding. Mean hospital stay was 2.75 days, with no airway compromise, catastrophic bleeding, or significant swallowing dysfunction. CONCLUSION: CO₂ laser dissection in TORS for OPSCC represents a viable surgical approach with acceptable postoperative functional outcomes and may possibly demonstrate reduced thermal injury compared with monopolar electrocautery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。